Patents by Inventor Robert Testman

Robert Testman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
    Publication number: 20050267201
    Abstract: Pharmaceutical compositions for oral administration to mammalian subjects comprise a taxane or taxane derivative (e.g., paclitaxel or docetaxel) as active ingredient and a vehicle comprising at least 30% by weight of a carrier for the taxane, said carrier having an HLB value of at least about 10. The compositions may also comprise 0-70% of a viscosity-reducing co-solubilizer. The compositions may be incorporated into conventional oral pharmaceutical dosage forms, or can be in the form of a two-part medicament wherein the first part includes the taxane in a solubilizing vehicle and the second part comprises a carrier for the taxane to promote oral absorption. Methods of treatment of taxane-responsive disease conditions employing the novel compositions are also disclosed, whereby the compositions can be administered alone or in association with an oral bioavailability enhancing agent.
    Type: Application
    Filed: June 24, 2005
    Publication date: December 1, 2005
    Applicant: Baker Norton Pharmaceuticals, Inc.
    Inventors: Jose Gutierrez-Rocca, Janice Cacace, Sami Selim, Robert Testman, J. Rutledge
  • Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
    Patent number: 6964946
    Abstract: Pharmaceutical compositions for oral administration to mammalian subjects comprise a taxane or taxane derivative (e.g., paclitaxel or docetaxel) as active ingredient and a vehicle comprising at least 30% by weight of a carrier for the taxane, said carrier having an HLB value of at least about 10. The compositions may also comprise 0–70% of a viscosity-reducing co-solubilizer. The compositions may be incorporated into conventional oral pharmaceutical dosage forms, or can be in the form of a two-part medicament wherein the first part includes the taxane in a solubilizing vehicle and the second part comprises a carrier for the taxane to promote oral absorption. Methods of treatment of taxane-responsive disease conditions employing the novel compositions are also disclosed, whereby the compositions can be administered alone or in association with an oral bioavailability enhancing agent.
    Type: Grant
    Filed: April 6, 1998
    Date of Patent: November 15, 2005
    Assignee: Baker Norton Pharmaceuticals, Inc.
    Inventors: Jose C. Gutierrez-Rocca, Janice L. Cacace, Sami Selim, Robert Testman, J. Michael Rutledge
  • Method and compositions for treating impotence
    Patent number: 6056966
    Abstract: Pharmaceutical compositions in topical or parenteral form containing specific organic mono- or dinitrates, some of them novel compounds, are effective in treating male impotence and erectile dysfunction through topical or intracavernosal administration to the penis. Methods of treatment utilizing the mono- or dinitrate-containing compositions are also disclosed.
    Type: Grant
    Filed: May 18, 1998
    Date of Patent: May 2, 2000
    Assignee: Baker Norton Pharmaceuticals, Inc.
    Inventors: Sami Selim, Robert Testman, Ho-Leung Fung, John A. Bauer